These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34053315)
41. A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Chung MP; Valenzuela A; Li S; Catanese B; Stevens K; Fiorentino D; Strand V; Chung L Rheumatology (Oxford); 2022 May; 61(6):2441-2449. PubMed ID: 34718447 [TBL] [Abstract][Full Text] [Related]
42. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis. Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644 [TBL] [Abstract][Full Text] [Related]
43. Severe peripheral vascular deterioration in scleroderma. A case report. Posner MA; Herness D; Green S Acta Orthop Scand; 1980 Apr; 51(2):239-41. PubMed ID: 7435180 [TBL] [Abstract][Full Text] [Related]
44. Screening tool development for hand surgery referrals in systemic sclerosis. Marcatto de Abreu MF; Landim S; Yuamoto FY; Lins C; Magalhães EP; Etchebehere M Clinics (Sao Paulo); 2023; 78():100270. PubMed ID: 37597472 [TBL] [Abstract][Full Text] [Related]
45. Characteristics of Japanese patients with systemic sclerosis complicated with calcinosis. Takagi K; Kawamoto M; Higuchi T; Tochimoto A; Hirose H; Harigai M; Kawaguchi Y Int J Rheum Dis; 2021 Jun; 24(6):803-808. PubMed ID: 33909342 [TBL] [Abstract][Full Text] [Related]
46. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis. Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571 [TBL] [Abstract][Full Text] [Related]
47. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Cappelli L; Wigley FM Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127 [TBL] [Abstract][Full Text] [Related]
48. Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire. Saketkoo LA; Gordon JK; Fligelstone K; Mawdsley A; Chaudhry HA; Valenzuela A; Christensen A; Khalique SM; Jensen K; Weinmann SC; Busman E; Chung L; Hsu VM; Russell AM; Steen VD Rheum Dis Clin North Am; 2023 May; 49(2):463-481. PubMed ID: 37028847 [TBL] [Abstract][Full Text] [Related]
50. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy. Wasserman A; Brahn E Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974 [TBL] [Abstract][Full Text] [Related]
51. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M; Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617 [TBL] [Abstract][Full Text] [Related]
52. Surgery for sclerodactylia of the hand. Experience with six cases. Lipscomb PR; Simons GW; Winkelmann RK J Bone Joint Surg Am; 1969 Sep; 51(6):1112-7. PubMed ID: 5805413 [No Abstract] [Full Text] [Related]
53. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis. Radić M; Martinović Kaliterna D; Ljutić D Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431 [TBL] [Abstract][Full Text] [Related]
54. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study. Mizuno R; Fujimoto S; Saito Y; Nakamura S Eur J Heart Fail; 2010 Mar; 12(3):268-75. PubMed ID: 20071354 [TBL] [Abstract][Full Text] [Related]
55. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma. Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037 [TBL] [Abstract][Full Text] [Related]
56. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma. Chong WH; Saha BK; Beegle S Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077 [TBL] [Abstract][Full Text] [Related]
57. The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma). RODNAN GP Ann Intern Med; 1962 Mar; 56():422-39. PubMed ID: 14493143 [No Abstract] [Full Text] [Related]
58. Spontaneous Compartment Syndrome of the Hand in Systemic Sclerosis. Tanagho A; Hatab S; Youssef S; Ansara S Orthopedics; 2015 Sep; 38(9):e849-51. PubMed ID: 26375546 [TBL] [Abstract][Full Text] [Related]
59. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039 [TBL] [Abstract][Full Text] [Related]
60. Effects of splinting in the treatment of hand contractures in progressive systemic sclerosis. Seeger MW; Furst DE Am J Occup Ther; 1987 Feb; 41(2):118-21. PubMed ID: 3565526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]